Definition of disease-free survival: this is my truth-show me yours

被引：26

作者：

Chua, YJ ^{[1
]}

Sargent, D

Cunningham, D

机构：

[1] Royal Marsden Hosp, Dept Med, Surrey, England

[2] Mayo Clin & Mayo Fdn, Ctr Comprehens Canc, Div Biostat, Rochester, MN 55905 USA

来源：

ANNALS OF ONCOLOGY | 2005年 / 16卷 / 11期

关键词：

lymph node metastasis; melanoma; prognosis; RT-PCR; sentinel lymph node;

D O I：

10.1093/annonc/mdi373

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1719 / 1721

页数：3

共 20 条

[1] Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer [J].

Andre, T ;

Boni, C ;

Mounedji-Boudiaf, L ;

Navarro, M ;

Tabernero, J ;

Hickish, T ;

Topham, C ;

Zaninelli, M ;

Clingan, P ;

Bridgewater, J ;

Tabah-Fisch, I ;

de Gramont, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2343-2351

[2] Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer:: Results of a randomized trial [J].

André, T ;

Colin, P ;

Louvet, C ;

Gamelin, E ;

Bouche, O ;

Achille, E ;

Colbert, N ;

Boaziz, C ;

Piedbois, P ;

Tubiana-Mathieu, N ;

Boutan-Laroze, A ;

Flesch, M ;

Buyse, M ;

de Gramont, A .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (15) :2896-2903

[3]

[Anonymous], 1984, NEW ENGL J MED, V310, P737

[4] LEUKEMIA AND PRELEUKEMIA AFTER ADJUVANT TREATMENT OF GASTROINTESTINAL CANCER WITH SEMUSTINE (METHYL-CCNU) [J].

BOICE, JD ;

GREENE, MH ;

KILLEN, JY ;

ELLENBERG, SS ;

KEEHN, RJ ;

MCFADDEN, E ;

CHEN, TT ;

FRAUMENI, JF .

NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (18) :1079-1084

[5]

Gray RG, 2000, LANCET, V355, P1588

[6] LEVAMISOLE AND FLUOROURACIL FOR ADJUVANT THERAPY OF RESECTED COLON-CARCINOMA [J].

MOERTEL, CG ;

FLEMING, TR ;

MACDONALD, JS ;

HALLER, DG ;

LAURIE, JA ;

GOODMAN, PJ ;

UNGERLEIDER, JS ;

EMERSON, WA ;

TORMEY, DC ;

GLICK, JH ;

VEEDER, MH ;

MAILLIARD, JA .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (06) :352-358

[7] INTERGROUP STUDY OF FLUOROURACIL PLUS LEVAMISOLE AS ADJUVANT THERAPY FOR STAGE-II DUKES B2 COLON-CANCER [J].

MOERTEL, CG ;

FLEMING, TR ;

MACDONALD, JS ;

HALLER, DG ;

LAURIE, JA ;

TANGEN, CM ;

UNGERLEIDER, JS ;

EMERSON, WA ;

TORMEY, DC ;

GLICK, JH ;

VEEDER, MH ;

MAILLIARD, JA .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (12) :2936-2943

[8] FLUOROURACIL PLUS LEVAMISOLE AS EFFECTIVE ADJUVANT THERAPY AFTER RESECTION OF STAGE-III COLON-CARCINOMA - A FINAL REPORT [J].

MOERTEL, CG ;

FLEMING, TR ;

MACDONALD, JS ;

HALLER, DG ;

LAURIE, JA ;

TANGEN, CM ;

UNGERLEIDER, JS ;

EMERSON, WA ;

TORMEY, DC ;

GLICK, JH ;

VEEDER, MH ;

MAILLIARD, JA .

ANNALS OF INTERNAL MEDICINE, 1995, 122 (05) :321-326

[9] Clinical cardiac tolerability of trastuzumab [J].

Perez, EA ;

Rodeheffer, R .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (02) :322-329

[10]

SARGENT D, 2005, IN PRESS J CLIN ONCO

← 1 2 →